Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13
In our paper [...] View Full-Text
Klingler, M.; Rangger, C.; Summer, D.; Kaeopookum, P.; Decristoforo, C.; von Guggenberg, E. Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13. Pharmaceuticals 2019, 12, 88. https://doi.org/10.3390/ph12020088
Klingler M, Rangger C, Summer D, Kaeopookum P, Decristoforo C, von Guggenberg E. Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13. Pharmaceuticals. 2019; 12(2):88. https://doi.org/10.3390/ph12020088
Chicago/Turabian StyleKlingler, Maximilian; Rangger, Christine; Summer, Dominik; Kaeopookum, Piriya; Decristoforo, Clemens; von Guggenberg, Elisabeth. 2019. "Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13" Pharmaceuticals 12, no. 2: 88. https://doi.org/10.3390/ph12020088